An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals into the country earlier this month may have been the last straw for the Indian government battling counterfeit drugs.
Summons have been issued to carry out an all-India survey on the availability and the extent of spurious and sub-standard drugs in the country, while law enforcement agencies have been ordered to aggressively pursue counterfeiters and put them behind bars, reports The Pharma Letter’s India correspondent.
Fake drugs, that treat everything from cancer to erectile dysfunction, are a multibillion dollar industry. With many accusing fingers pointing to India, the country has decided to don battle gear against sub-standard pharmaceutical products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze